21/06/2024 - 11:22

Botanix taps investors for $70m

21/06/2024 - 11:22

Bookmark

Save articles for future reference.

Leederville-based medical dermatology company Botanix has announced it will tap investors for $70 million to fund the launch of its recently US Food and Drug Administration approved Sofdra gel.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options